Z-2633-2026 Class II Ongoing
FDA device recall Z-2633-2026 was initiated by Boston Scientific Corporation on May 21, 2026 and is designated Class II. Reason for recall: Potential sterile breach of the pouches in which devices are packaged. The recall status is ongoing. Affected quantity: 81,543 units.
Recall details
- Product Type
- Devices
- Report Date
- Jul 8, 2026
- Initiation Date
- May 21, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 81,543 units
Product description
Reason for recall
Distribution pattern
Worldwide distribution - US Nationwide and the countries of Australia, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Canada, Chile, China, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Estonia, Finland, France, Germany, Great Britain, Greece, Guatemala, Hong Kong, Hungary, India, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Latvia, Lebanon, Luxembourg, Malaysia, Mexico, Mongolia, Netherlands, New Zealand, Norway, Pakistan, Paraguay, Peru, Philippines, Poland, Portugal, Romania, Russian Federation, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Tobago, Trinidad, Tunisia, T¿rkiye, United Arab Emirates, Uruguay.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2633-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026